Prostatic Neoplasms, Castration-Resistant
4 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Androgen receptor signaling inhibitor (ARSI) + VIR-5500 for prostatic neoplasms, castration-resistant | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Androgen receptor signaling inhibitor (ARSI) + VIR-5500 + DOCETAXEL for prostatic neoplasms, castration-resistant | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Omeprazole 80 mg twice daily for prostatic neoplasms, castration-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VIR-5500 for prostatic neoplasms, castration-resistant | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |